Oncology Clinical Trials
Dogs are helping scientists discover better cancer treatments
A news team from Atlanta’s WSB-TV, an ABC-affiliate TV station, visited the Purdue University Veterinary Hospital recently to report on the game-changing possibilities of clinical trials involving naturally occurring cancer in dogs. In the full video, Anchor/Reporter Tom Regan described research led by Dr. Deborah Knapp, Dolores L. McCall Professor of Comparative Oncology and director of the Purdue Comparative Oncology Program (PCOP). The story explained how comparative oncology research in dogs holds promise for speeding up the development of cancer-fighting drugs.
Current Clinical Trials
Canine Oral Squamous Cell Carcinoma
Pilot study involving a novel nanoparticle radiosensitizer in pet dogs with squamous cell carcinoma of the oral cavity.
Learn more about our Canine Oral Squamous Cell Carcinoma Trial >>
Canine Splenic Hemangiosarcoma
Clinical evaluation of propranolol in combination with doxorubicin for the treatment of splenic hemangiosarcoma in dogs.
Learn more about our Splenic Hemangiosarcoma Clinical Trial >>
Canine Urinary Bladder Cancer
In 2022, the PCOP is opening a new trial for dogs with urinary bladder cancer (TCC) affecting the bladder and/or urethra. The study is aimed at learning how the dog’s immune system can be stimulated to attack the cancer.
Learn more about our Canine Urinary Bladder Cancer Trial >>
Canine Multicentric Lymphoma Clinical Trials
Biodynamic Imaging (BDI) as a Promising Strategy for Personalized Therapy of Canine Diffuse Large B-cell Lymphoma
Biodynamic Testing of Chemotherapy Sensitivity in Dogs Receiving Gemcitabine for Cutaneous T-cell Lymphoma
Make a Donation to Support
Cancer Research
PCOP Newsletters
Visiting Us
Directions to the Purdue University Veterinary HospitalDr. Knapp on PCOP
Clinical Trials in Dogs with Cancer: Frequently Asked Questions